Efficacy of Lenvatinib versus Bevacizumab in Triple Therapy with Immune Checkpoint Inhibitors and Interventional Therapy for Hepatocellular Carcinoma with Macrovascular Invasion: A Multi-Center Real-World Retrospective Study.
- DOI
- 10.2147/jhc.s640366
- Published
- 2026
- Container
- Journal of hepatocellular carcinoma
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/jhc.s640366,
title = {Efficacy of Lenvatinib versus Bevacizumab in Triple Therapy with Immune Checkpoint Inhibitors and Interventional Therapy for Hepatocellular Carcinoma with Macrovascular Invasion: A Multi-Center Real-World Retrospective Study.},
author = {Zhang J and Liu Y and Ding Y and Deng Z and Jiang B and Gao B and Hu S and Sun J and Yang X and Zhang H and Li B},
year = {2026},
journal = {Journal of hepatocellular carcinoma},
doi = {10.2147/jhc.s640366},
url = {https://doi.org/10.2147/jhc.s640366}
}RIS
TY - JOUR TI - Efficacy of Lenvatinib versus Bevacizumab in Triple Therapy with Immune Checkpoint Inhibitors and Interventional Therapy for Hepatocellular Carcinoma with Macrovascular Invasion: A Multi-Center Real-World Retrospective Study. AU - Zhang J AU - Liu Y AU - Ding Y AU - Deng Z AU - Jiang B AU - Gao B AU - Hu S AU - Sun J AU - Yang X AU - Zhang H AU - Li B PY - 2026 JO - Journal of hepatocellular carcinoma DO - 10.2147/jhc.s640366 UR - https://doi.org/10.2147/jhc.s640366 ER -
APA
J, Z., Y, L., Y, D., Z, D., B, J., B, G., S, H., J, S., X, Y., H, Z., & B, L. (2026). Efficacy of Lenvatinib versus Bevacizumab in Triple Therapy with Immune Checkpoint Inhibitors and Interventional Therapy for Hepatocellular Carcinoma with Macrovascular Invasion: A Multi-Center Real-World Retrospective Study.. Journal of hepatocellular carcinoma. https://doi.org/10.2147/jhc.s640366
Source records
- pubmed · retrieved 2026-09-27T12:38:25.103Z